阿尔茨海默病:一个拼图由不同类型的编程细胞死亡碎片组成
1Institute of Traditional Chinese Medicine of Sichuan Academy of Chinese Medicine Sciences, China.
Brain research
|July 25, 2025
概括
阿尔茨海默病的发病过程涉及多种编程细胞死亡 (PCD) 途径,而不仅仅是孤立的. 本综述综合了各种PCD类型和金属离子在神经退行过程中的作用.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,影响全球数百万人,预计随着人口老龄化而增加.
- 阿尔茨海默病理包括粉样斑块,神经纤维状,以及由于神经元死亡而导致的显著神经退行.
- 现有的审查往往缺乏全面的机制整合编程细胞死亡 (PCD) 在AD.
研究的目的:
- 系统地评估所有与阿尔茨海默病 (AD) 相关的编程细胞死亡 (PCD) 途径.
- 强调多种PCD类型在AD病变发生过程中的联合参与,超越孤立路径分析.
- 讨论价值变量金属离子在AD病变发生中的作用.
主要方法:
- 对AD中PCD途径的实验研究进行系统审查.
- 分析文献,将各种PCD类型 (亡,自,亡,亡,亡,亡,亡,亡,亡,NETosis,亡,亡) 与AD联系起来.
- 整合了关于金属离子参与AD的发现.
主要成果:
- 多种编程细胞死亡 (PCD) 途径,包括亡,自,亡,帕尔塔纳托斯,亡,亡,Pyroptosis,NETosis,ferroptosis和cuproptosis,都与阿尔茨海默病有关.
- 阿尔茨海默氏病变的特征是多个PCD途径的协同作用,而不是单一的机制.
- 价值变量的金属离子在AD的发展和进展中起着重要作用.
结论:
- 阿尔茨海默病的发病过程是一个复杂的过程,由多种编程细胞死亡途径的相互作用驱动.
- 了解各种PCD机制和金属离子作用的综合作用对于开发有效的AD疗法至关重要.
- 本综述提供了PCD在AD中全面的机制整合,突出了神经退行症的多途径模型.
相关概念视频
Overview of Cell Death
7.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.8K
Apoptosis
12.0K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K
Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Phagocytosis of Apoptotic Cells
4.0K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
4.0K
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669


